{"id":9667,"date":"2026-03-18T11:22:37","date_gmt":"2026-03-18T03:22:37","guid":{"rendered":"https:\/\/regask.com\/?p=9667"},"modified":"2026-03-18T11:22:37","modified_gmt":"2026-03-18T03:22:37","slug":"grece-eof-rouvre-sa-plateforme-pour-les-declarations-dauthenticite-sur-les-emballages-pharmaceutiques","status":"publish","type":"post","link":"https:\/\/regask.com\/fr\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\/","title":{"rendered":"L&#039;EOF grecque rouvre sa plateforme de v\u00e9rification d&#039;authenticit\u00e9\u2026"},"content":{"rendered":"<p><span data-contrast=\"auto\">Sur\u00a0<\/span><b><span data-contrast=\"auto\">9 mars 2026<\/span><\/b><span data-contrast=\"auto\">, L\u2019Organisation nationale des m\u00e9dicaments a annonc\u00e9 la r\u00e9ouverture temporaire de sa plateforme de soumission num\u00e9rique pour les\u00a0<\/span><b><span data-contrast=\"auto\">\u00e9tiquettes d&#039;authenticit\u00e9 appos\u00e9es sur les emballages pharmaceutiques<\/span><\/b><span data-contrast=\"auto\">. La mise \u00e0 jour cible sp\u00e9cifiquement\u00a0<\/span><b><span data-contrast=\"auto\">Titulaires d&#039;autorisation de mise sur le march\u00e9 (AMM)<\/span><\/b><span data-contrast=\"auto\">\u00a0et\u00a0<\/span><b><span data-contrast=\"auto\">repr\u00e9sentants locaux responsables des m\u00e9dicaments commercialis\u00e9s en Gr\u00e8ce<\/span><\/b><span data-contrast=\"auto\">.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">La p\u00e9riode de soumission est ouverte \u00e0 partir de\u00a0<\/span><b><span data-contrast=\"auto\">Du 9 mars 2026 \u00e0 8h00 au 10 mars 2026 \u00e0 23h59<\/span><\/b><span data-contrast=\"auto\">, permettant aux parties prenantes de d\u00e9clarer l&#039;authenticit\u00e9 des enregistrements qui \u00e9taient\u00a0<\/span><b><span data-contrast=\"auto\">d\u00e9j\u00e0 demand\u00e9es pour les emballages pharmaceutiques, mais n&#039;ont pas \u00e9t\u00e9 signal\u00e9es dans les d\u00e9lais l\u00e9gaux initiaux du 20 f\u00e9vrier 2026.<\/span><\/b><span data-contrast=\"auto\">. Cette initiative s&#039;inscrit dans le cadre de l&#039;application par l&#039;EOF de\u00a0<\/span><b><span data-contrast=\"auto\">r\u00e9glementation sur la s\u00e9rialisation des produits pharmaceutiques et la lutte contre la contrefa\u00e7on<\/span><\/b><span data-contrast=\"auto\">\u00a0conform\u00e9ment \u00e0 la l\u00e9gislation grecque applicable.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<div class=\"row\"  id=\"row-1131748571\">\n\n\t<div id=\"col-637783614\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\t<div id=\"gap-1073439968\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1073439968 {\n  padding-top: 20px;\n}\n<\/style>\n\t<\/div>\n\t\n<h2>D\u00e9tails de la mise \u00e0 jour<\/h2>\n\t<div id=\"gap-1612531880\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1612531880 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span data-contrast=\"auto\">La plateforme rouverte offre une\u00a0<\/span><b><span data-contrast=\"auto\">Possibilit\u00e9 limit\u00e9e de double confirmation de l&#039;authenticit\u00e9 des enregistrements<\/span><\/b><span data-contrast=\"auto\">. Cette mesure permet aux titulaires d&#039;autorisation de mise sur le march\u00e9 et aux repr\u00e9sentants locaux de soumettre des d\u00e9clarations pour des enregistrements qui \u00e9taient auparavant omis des soumissions dues avant la date limite.\u00a0<\/span><b><span data-contrast=\"auto\">Date limite : 20 f\u00e9vrier 2026<\/span><\/b><span data-contrast=\"auto\">.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">La fen\u00eatre de d\u00e9claration est strictement limit\u00e9e \u00e0\u00a0<\/span><b><span data-contrast=\"auto\">des bandes d&#039;authentification d\u00e9j\u00e0 appos\u00e9es sur les emballages pharmaceutiques<\/span><\/b><span data-contrast=\"auto\">\u00a0mais n&#039;ont pas \u00e9t\u00e9 signal\u00e9es lors de la p\u00e9riode de d\u00e9claration initiale. Aucune nouvelle demande n&#039;est concern\u00e9e par cette r\u00e9ouverture.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">EOF souligne que\u00a0<\/span><b><span data-contrast=\"auto\">Une conformit\u00e9 rapide et compl\u00e8te est requise.<\/span><\/b><span data-contrast=\"auto\">, notant que le fait de ne pas signaler les enregistrements d&#039;authenticit\u00e9 pourrait entra\u00eener\u00a0<\/span><b><span data-contrast=\"auto\">mesures d&#039;application de la r\u00e9glementation ou sanctions<\/span><\/b><span data-contrast=\"auto\">. Cette mise \u00e0 jour confirme l&#039;importance que le r\u00e9gulateur accorde \u00e0 ce sujet.\u00a0<\/span><b><span data-contrast=\"auto\">tra\u00e7abilit\u00e9, authenticit\u00e9 des produits et mesures de lutte contre la contrefa\u00e7on au sein de la cha\u00eene d&#039;approvisionnement pharmaceutique en Gr\u00e8ce<\/span><\/b><span data-contrast=\"auto\">.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-637783614 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-528135646\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Date limite de retour d&#039;information<\/h2>\n\t<div id=\"gap-1518148825\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1518148825 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span class=\"TextRun SCXW230829425 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW230829425 BCX0\">La plateforme de soumission EOF permettant de d\u00e9clarer des enregistrements d&#039;authenticit\u00e9 non signal\u00e9s pr\u00e9c\u00e9demment restera ouverte.\u00a0<\/span><\/span><span class=\"TextRun MacChromeBold SCXW230829425 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW230829425 BCX0\">depuis <strong>Du 9 mars 2026 (08:00) au 10 mars 2026 (23:59)<\/strong><\/span><\/span><strong><span class=\"TextRun SCXW230829425 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW230829425 BCX0\">.<\/span><\/span><span class=\"EOP SCXW230829425 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/strong><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-528135646 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1280022611\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Pourquoi c&#039;est important<\/h2>\n\t<div id=\"gap-2000629823\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-2000629823 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>Cette mise \u00e0 jour renforce la surveillance r\u00e9glementaire relative \u00e0 <strong>conformit\u00e9 en mati\u00e8re de s\u00e9rialisation et de lutte contre la contrefa\u00e7on<\/strong> sur le march\u00e9 pharmaceutique grec. En accordant une courte p\u00e9riode de r\u00e9ouverture des d\u00e9clarations, l&#039;EOF favorise une am\u00e9lioration <strong>exactitude des donn\u00e9es, tra\u00e7abilit\u00e9 et transparence de la cha\u00eene d&#039;approvisionnement,<\/strong> tout en maintenant <strong>coh\u00e9rence r\u00e9glementaire et perturbations op\u00e9rationnelles minimales<\/strong> pour les entreprises concern\u00e9es.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1280022611 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-279185944\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>\u00c0 qui cela s&#039;adresse-t-il ?<\/h2>\n\t<div id=\"gap-69880715\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-69880715 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>Cette annonce est particuli\u00e8rement pertinente pour <strong>Titulaires d&#039;autorisation de mise sur le march\u00e9, repr\u00e9sentants pharmaceutiques locaux, \u00e9quipes des affaires r\u00e9glementaires, professionnels de l&#039;assurance qualit\u00e9 et \u00e9quipes de conformit\u00e9<\/strong> responsable de <strong>Distribution, d\u00e9claration et contr\u00f4le r\u00e9glementaire des m\u00e9dicaments en Gr\u00e8ce. <\/strong><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-279185944 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-90732230\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Prochaines \u00e9tapes<\/h2>\n\t<div id=\"gap-1866401139\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1866401139 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span data-contrast=\"auto\">Les \u00e9quipes r\u00e9glementaires devraient\u00a0<\/span><b><span data-contrast=\"auto\">examiner les dossiers des demandes de bandes d&#039;authentification<\/span><\/b><span data-contrast=\"auto\">\u00a0et les v\u00e9rifier par rapport \u00e0\u00a0<\/span><b><span data-contrast=\"auto\">soumissions pr\u00e9c\u00e9dentes effectu\u00e9es avant la date limite du 20 f\u00e9vrier 2026<\/span><\/b><span data-contrast=\"auto\">. Toute omission doit \u00eatre rapidement identifi\u00e9e et les d\u00e9clarations requises doivent \u00eatre soumises via la plateforme EOF.\u00a0<\/span><b><span data-contrast=\"auto\">durant la p\u00e9riode de r\u00e9ouverture, du 9 au 10 mars 2026<\/span><\/b><span data-contrast=\"auto\">\u00a0afin d&#039;\u00e9viter les risques potentiels de non-conformit\u00e9.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Les organisations op\u00e9rant sur plusieurs march\u00e9s r\u00e9glement\u00e9s sont souvent confront\u00e9es \u00e0 des mises \u00e0 jour r\u00e9glementaires similaires, annonc\u00e9es \u00e0 la derni\u00e8re minute. Les plateformes telles que\u00a0<\/span><b><span data-contrast=\"auto\">RegASK<\/span><\/b><span data-contrast=\"auto\">\u00a0Aider les \u00e9quipes de conformit\u00e9 et de r\u00e9glementation \u00e0 surveiller les changements, \u00e0 suivre les obligations et \u00e0 rationaliser les soumissions dans toutes les juridictions.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\"><a href=\"http:\/\/regask.com\/fr\/\"><strong>RegASK<\/strong><\/a>\u00a0est une plateforme de pointe d&#039;intelligence r\u00e9glementaire et d&#039;orchestration des flux de travail bas\u00e9e sur l&#039;IA agentique, qui permet aux organisations internationales des secteurs fortement r\u00e9glement\u00e9s, tels que les produits de consommation et les sciences de la vie, d&#039;anticiper les complexit\u00e9s r\u00e9glementaires. En combinant une IA agentique avanc\u00e9e et l&#039;expertise de sp\u00e9cialistes,\u00a0<a href=\"http:\/\/regask.com\/fr\/\"><strong>RegASK<\/strong><\/a>\u00a0Elle fournit en temps opportun des informations pr\u00e9dictives exploitables et une automatisation de bout en bout, rationalisant les processus de conformit\u00e9, att\u00e9nuant les risques et acc\u00e9l\u00e9rant l&#039;acc\u00e8s au march\u00e9 dans plus de 160 pays. <a href=\"http:\/\/regask.com\/fr\/\"><strong>En savoir plus <\/strong><\/a>ou<a href=\"https:\/\/regask.com\/fr\/reserver-une-demo\/\"><strong> r\u00e9servez une d\u00e9mo maintenant.<\/strong><\/a><\/span><strong>\u00a0<\/strong><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-90732230 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>\n<div class=\"row\"  id=\"row-1241020083\">\n\n\t<div id=\"col-1398031596\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<div class=\"is-divider divider clearfix\" style=\"margin-top:2em;margin-bottom:2em;max-width:20%;height:1px;background-color:#a5acd9;\"><\/div>\n<h3>FAQ<\/h3>\n\t<div id=\"gap-660792758\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-660792758 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<h4><span class=\"TextRun MacChromeBold SCXW267956491 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW267956491 BCX0\" data-ccp-parastyle=\"heading 3\">Quelles sont les nouvelles recommandations du CDE concernant les essais cliniques des vaccins contre la grippe\u00a0?<\/span><\/span><span class=\"EOP SCXW267956491 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559738&quot;:281,&quot;335559739&quot;:281}\">\u00a0<\/span><\/h4>\n\t<div id=\"gap-904718601\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-904718601 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><strong>R\u00e9unions sur le portefeuille et la technologie (PTM)<\/strong> sont des r\u00e9unions virtuelles structur\u00e9es organis\u00e9es par <strong>Agence europ\u00e9enne des m\u00e9dicaments<\/strong> permettre aux grandes entreprises pharmaceutiques de discuter <strong>d\u00e9fis li\u00e9s au d\u00e9veloppement de portefeuilles de produits et technologies \u00e9mergentes<\/strong> avec l&#039;organisme de r\u00e9glementation.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1398031596 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-453688499\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h4><span class=\"TextRun MacChromeBold SCXW184197477 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW184197477 BCX0\" data-ccp-parastyle=\"heading 3\">Qui peut candidater aux r\u00e9unions EMA sur le portefeuille et la technologie\u00a0?<\/span><\/span><span class=\"EOP SCXW184197477 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559738&quot;:281,&quot;335559739&quot;:281}\">\u00a0<\/span><\/h4>\n\t<div id=\"gap-1311492371\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1311492371 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>Le programme PTM est ouvert \u00e0 <strong>grandes entreprises pharmaceutiques poss\u00e9dant de vastes portefeuilles de produits m\u00e9dicinaux.<\/strong> Les entreprises \u00e9ligibles doivent soumettre un formulaire de demande \u00e0 l&#039;EMA pour examen.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-453688499 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-552123153\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h4><span class=\"TextRun MacChromeBold SCXW3460145 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW3460145 BCX0\" data-ccp-parastyle=\"heading 3\">Quelle est la date limite pour d\u00e9poser une demande de PTM en 2026\u00a0?<\/span><\/span><span class=\"EOP SCXW3460145 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559738&quot;:281,&quot;335559739&quot;:281}\">\u00a0<\/span><\/h4>\n\t<div id=\"gap-928476110\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-928476110 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>Le <strong>La date limite de d\u00e9p\u00f4t des candidatures est le 30 avril 2026.<\/strong> Le <strong>L\u2019EMA communiquera les r\u00e9sultats des demandes d\u2019ici la fin du mois de mai 2026.,<\/strong> et les r\u00e9unions approuv\u00e9es auront lieu dans le <strong>seconde moiti\u00e9 de 2026. <\/strong><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-552123153 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1818114804\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h4><span class=\"TextRun MacChromeBold SCXW14904628 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW14904628 BCX0\" data-ccp-parastyle=\"heading 3\">Comment peut-on\u00a0<\/span><span class=\"NormalTextRun SpellingErrorV2Themed SCXW14904628 BCX0\" data-ccp-parastyle=\"heading 3\">RegASK<\/span><span class=\"NormalTextRun SCXW14904628 BCX0\" data-ccp-parastyle=\"heading 3\">\u00a0Comment aider les organisations \u00e0 g\u00e9rer des mises \u00e0 jour comme celle-ci\u00a0?<\/span><\/span><span class=\"EOP SCXW14904628 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559738&quot;:281,&quot;335559739&quot;:281}\">\u00a0<\/span><\/h4>\n\t<div id=\"gap-1463045301\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1463045301 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span class=\"TextRun MacChromeBold SCXW253285960 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><a href=\"http:\/\/regask.com\/fr\/\"><strong><span class=\"NormalTextRun SpellingErrorV2Themed SCXW253285960 BCX0\">RegASK<\/span><\/strong><\/a><span class=\"NormalTextRun SCXW253285960 BCX0\">\u00a0<strong>plateforme de veille r\u00e9glementaire IA agentique<\/strong><\/span><\/span><span class=\"TextRun SCXW253285960 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW253285960 BCX0\">aide les entreprises pharmaceutiques\u00a0<\/span><\/span><span class=\"NormalTextRun SCXW253285960 BCX0\">moniteur<\/span><strong><span class=\"TextRun MacChromeBold SCXW253285960 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW253285960 BCX0\">Annonces r\u00e9glementaires mondiales, possibilit\u00e9s d&#039;engagement et programmes de consultation<\/span><\/span><\/strong><span class=\"TextRun SCXW253285960 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW253285960 BCX0\">\u00a0en temps r\u00e9el. Cela permet aux \u00e9quipes de r\u00e9glementation de\u00a0<\/span><span class=\"NormalTextRun SCXW253285960 BCX0\">identifier<\/span><span class=\"NormalTextRun SCXW253285960 BCX0\">\u00a0des initiatives telles que\u00a0<\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW253285960 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW253285960 BCX0\">R\u00e9unions sur le portefeuille et la technologie de l&#039;EMA<\/span><\/span><\/strong><span class=\"TextRun SCXW253285960 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW253285960 BCX0\"><strong>,<\/strong> coordonner la pr\u00e9paration interne et\u00a0<\/span><span class=\"NormalTextRun SCXW253285960 BCX0\">maintenir<\/span><span class=\"NormalTextRun SCXW253285960 BCX0\">\u00a0Pr\u00e9paration \u00e0 la conformit\u00e9 dans le cadre de pipelines mondiaux complexes.<\/span><\/span><span class=\"EOP SCXW253285960 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1818114804 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Le 9 mars 2026, l&#039;Organisation nationale des m\u00e9dicaments a annonc\u00e9 la r\u00e9ouverture temporaire de sa plateforme de soumission num\u00e9rique pour les \u00e9tiquettes d&#039;authenticit\u00e9 appos\u00e9es sur les emballages pharmaceutiques. Cette mise \u00e0 jour s&#039;adresse sp\u00e9cifiquement aux titulaires d&#039;autorisation de mise sur le march\u00e9 (AMM) et aux repr\u00e9sentants locaux responsables des m\u00e9dicaments commercialis\u00e9s en Gr\u00e8ce. La p\u00e9riode de soumission est ouverte du 9 mars 2026 \u00e0 8h00 au 10 mars 2026 \u00e0 17h00.<\/p>","protected":false},"author":41,"featured_media":9668,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[33,35,556],"tags":[],"class_list":["post-9667","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-pharma-biotech-latest-insights","category-greece-regulations"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.3 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Greece\u2019s EOF Reopens Platform for Compliance Updates<\/title>\n<meta name=\"description\" content=\"Greece\u2019s EOF reopens the platform for authenticity tape declarations on pharmaceutical packaging from March 9 to March 10, 2026.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/fr\/grece-eof-rouvre-sa-plateforme-pour-les-declarations-dauthenticite-sur-les-emballages-pharmaceutiques\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Greece\u2019s EOF Reopens Platform for Authenticity Tape Declarations on Pharmaceutical Packaging\" \/>\n<meta property=\"og:description\" content=\"Greece\u2019s EOF reopens the platform for authenticity tape declarations on pharmaceutical packaging from March 9 to March 10, 2026.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/fr\/grece-eof-rouvre-sa-plateforme-pour-les-declarations-dauthenticite-sur-les-emballages-pharmaceutiques\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-18T03:22:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2026\/03\/greece-eof-reopens-platform-authenticity-tape-declarations-pharmaceutical-packaging.png\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Shaffa Renaningtyas\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Shaffa Renaningtyas\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\\\/\"},\"author\":{\"name\":\"Shaffa Renaningtyas\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/b0e1938ef6f244f9f052a21f21cba1b6\"},\"headline\":\"Greece\u2019s EOF Reopens Platform for Authenticity Tape D&hellip;\",\"datePublished\":\"2026-03-18T03:22:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\\\/\"},\"wordCount\":822,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/greece-eof-reopens-platform-authenticity-tape-declarations-pharmaceutical-packaging.png\",\"articleSection\":[\"Regulatory News\",\"Pharma and Biotech\",\"Greece\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\\\/\",\"name\":\"Greece\u2019s EOF Reopens Platform for Compliance Updates\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/greece-eof-reopens-platform-authenticity-tape-declarations-pharmaceutical-packaging.png\",\"datePublished\":\"2026-03-18T03:22:37+00:00\",\"description\":\"Greece\u2019s EOF reopens the platform for authenticity tape declarations on pharmaceutical packaging from March 9 to March 10, 2026.\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/regask.com\\\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/greece-eof-reopens-platform-authenticity-tape-declarations-pharmaceutical-packaging.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/greece-eof-reopens-platform-authenticity-tape-declarations-pharmaceutical-packaging.png\",\"width\":800,\"height\":600,\"caption\":\"Greece Eof Reopens Platform Authenticity Tape Declarations Pharmaceutical Packaging\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"Empowering Smarter Regulatory Decisions\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\",\"name\":\"RegASK\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"width\":401,\"height\":401,\"caption\":\"RegASK\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RegASKRegulatoryAffairs\\\/\",\"https:\\\/\\\/x.com\\\/ASKRegASK\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/RegASK\\\/\",\"https:\\\/\\\/www.youtube.com\\\/playlist?list=PL6yPC6gFqelkHbOeyUVKjtHOZXZ2LQbJd\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/b0e1938ef6f244f9f052a21f21cba1b6\",\"name\":\"Shaffa Renaningtyas\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"L&#039;EOF grecque rouvre sa plateforme de mise \u00e0 jour en mati\u00e8re de conformit\u00e9.","description":"L&#039;EOF grecque rouvre la plateforme pour les d\u00e9clarations d&#039;authenticit\u00e9 sur les emballages pharmaceutiques du 9 au 10 mars 2026.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/fr\/grece-eof-rouvre-sa-plateforme-pour-les-declarations-dauthenticite-sur-les-emballages-pharmaceutiques\/","og_locale":"fr_FR","og_type":"article","og_title":"Greece\u2019s EOF Reopens Platform for Authenticity Tape Declarations on Pharmaceutical Packaging","og_description":"Greece\u2019s EOF reopens the platform for authenticity tape declarations on pharmaceutical packaging from March 9 to March 10, 2026.","og_url":"https:\/\/regask.com\/fr\/grece-eof-rouvre-sa-plateforme-pour-les-declarations-dauthenticite-sur-les-emballages-pharmaceutiques\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2026-03-18T03:22:37+00:00","og_image":[{"width":800,"height":600,"url":"https:\/\/regask.com\/wp-content\/uploads\/2026\/03\/greece-eof-reopens-platform-authenticity-tape-declarations-pharmaceutical-packaging.png","type":"image\/png"}],"author":"Shaffa Renaningtyas","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"Written by":"Shaffa Renaningtyas","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\/#article","isPartOf":{"@id":"https:\/\/regask.com\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\/"},"author":{"name":"Shaffa Renaningtyas","@id":"https:\/\/regask.com\/#\/schema\/person\/b0e1938ef6f244f9f052a21f21cba1b6"},"headline":"Greece\u2019s EOF Reopens Platform for Authenticity Tape D&hellip;","datePublished":"2026-03-18T03:22:37+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\/"},"wordCount":822,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/03\/greece-eof-reopens-platform-authenticity-tape-declarations-pharmaceutical-packaging.png","articleSection":["Regulatory News","Pharma and Biotech","Greece"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/regask.com\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\/","url":"https:\/\/regask.com\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\/","name":"L&#039;EOF grecque rouvre sa plateforme de mise \u00e0 jour en mati\u00e8re de conformit\u00e9.","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/03\/greece-eof-reopens-platform-authenticity-tape-declarations-pharmaceutical-packaging.png","datePublished":"2026-03-18T03:22:37+00:00","description":"L&#039;EOF grecque rouvre la plateforme pour les d\u00e9clarations d&#039;authenticit\u00e9 sur les emballages pharmaceutiques du 9 au 10 mars 2026.","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/regask.com\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2026\/03\/greece-eof-reopens-platform-authenticity-tape-declarations-pharmaceutical-packaging.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/03\/greece-eof-reopens-platform-authenticity-tape-declarations-pharmaceutical-packaging.png","width":800,"height":600,"caption":"Greece Eof Reopens Platform Authenticity Tape Declarations Pharmaceutical Packaging"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"Favoriser des d\u00e9cisions r\u00e9glementaires plus intelligentes","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/regask.com\/#organization","name":"RegASK","url":"https:\/\/regask.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/","url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","width":401,"height":401,"caption":"RegASK"},"image":{"@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","https:\/\/x.com\/ASKRegASK","https:\/\/www.linkedin.com\/company\/RegASK\/","https:\/\/www.youtube.com\/playlist?list=PL6yPC6gFqelkHbOeyUVKjtHOZXZ2LQbJd"]},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/b0e1938ef6f244f9f052a21f21cba1b6","name":"Shaffa Renaningtyas"}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/posts\/9667","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/users\/41"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/comments?post=9667"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/posts\/9667\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/media\/9668"}],"wp:attachment":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/media?parent=9667"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/categories?post=9667"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/tags?post=9667"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}